Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Short-course Radiation and Oxaliplatin-based Consolidation Chemotherapy for Locally Advanced Rectal Cancer
KCT0004874Phase 2Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Oct 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in rectal cancer, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Oct 2020; status: recruiting.
02
Drugs
oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on KCT0004874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004874.